Medical student perspectives on evidence

888 views

Published on

Published in: Education
1 Comment
0 Likes
Statistics
Notes
  • Very interesting & impressive presentation! Excellently & superbly composed! Thank you for sharing...
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

No Downloads
Views
Total views
888
On SlideShare
0
From Embeds
0
Number of Embeds
33
Actions
Shares
0
Downloads
11
Comments
1
Likes
0
Embeds 0
No embeds

No notes for slide

Medical student perspectives on evidence

  1. 1. !"#$%&'()*+#",*(-"./0"%12"/(3,(42$#",%"(&,# 42$#",%"56&/"#(!"#$%$,"(7"/3+.%"/ Mark MacEachern, MLIS; Whitney Townsend, MILS; Gurpreet Rana, MLIS; Abby Bedford, MSI; Rajesh S. Mangrulkar, MD 869"%12" To determine which resources second‐year medical school students tend to use most  Cases !"#$%#&'()*'+*,&-.#"*/(0&0/,(*$%#-1+&-*,&2*.30/3*"#-+%"/#-*'3#)*4#"/#05#*4"+502#* >&/"(?()+@@&.A(5(>&.#$3@A30&*=AB((!.C(D '3#*3063#-'*(#5#(*+!*#502#&/#7 W"7*Z*0-*[*)#,"-*+(27*W"7*Z*/+84(,0&-*+!*!,16%#*,&2*;"#,'3(#--&#--*+&*,/150')7*]#* 8%-'*-'+4*.3#&*/(08;0&6*+&#*^063'*+!*-',0"-?*,&2*3,-*&+'*;##&*,;(#*'+*6#'*'3"+%63*30-* &+"8,(* 2,)Q-* .+"9* CL:_K* 3+%"-D* !+"* ,(8+-'* ,* 8+&'37* W"7* Z* -,)-* '3,'* 3#* 3,-* 3,2* :&%;<.3+,# `;+"2#"(0&#a*3)4#"'#&-0+&*0&*'3#*4,-'?*;%'*.,-*&#5#"*'+(2*'+*',9#*8#20/,1+&7**]#*3,-* At strategic points throughout the undergraduate medical school curriculum, health  &+*9&+.&*30-'+")*+!*/+"+&,")*,"'#")*20-#,-#7*W"7*ZQ-*!,80()*30-'+")*0-*-06&0H/,&'*!+"* sciences  librarians  collaborate  with  medical  school  faculty  to  teach  sessions  on  20,;#'#-?* 3)4#"'#&-0+&?* ,&2* /+"+&,")* ,"'#")* 20-#,-#7* ZJ#"* ,* /,"#!%(* 30-'+")* ,&2* 8#20/,(*2#/0-0+&*8,90&6*,&2*#502#&/#:;,-#2*8#20/0&#*"#-+%"/#-7*<&*4"#4,",1+&*!+"* 43)-0/,(*#I,80&,1+&*,&2*/+&-02#",1+&*+!*'3#*'#-'*"#-%('-?*W"7*ZQ-*43)-0/0,&*'#((-*308* a session that occurs during the M2 year, medical students are required to complete  '3,'*3#*3,-*/+&6#-15#*3#,"'*!,0(%"#?*-#/+&2,")*'+*/,"20+8)+4,'3)7 ,&* ,--06&8#&'* '3,'* ,-9-* '3#8* '+* -#,"/3* -#5#",(* "#-+%"/#-* '+* 2#5#(+4* ;+=+8:(0&#* E+"/13,* :* Y-0&6* '3#* STOU?* B%;8#2* CUSA* (080'D?* ,&2* ,* "#-+%"/#* +!* )+%"* /3+0/#?* ,&-.#"-* '+* '.+* /(0&0/,(* $%#-1+&-7* >+"* #,/3* $%#-1+&?* '3#* -'%2#&'-* -#,"/3* '.+* 2#'#"80&#*.3#'3#"*-',"1&6*206+I0&*C2060',(0-D*,-*4,"'*+!*W"7*ZQ-*8#20/,1+&*"#608#&* resources selected by the instructors and one resource of their choosing.  To get a  .+%(2*;#&#H'*308b*<!*-+?*0&*.3,'*.,)C-Db* -#&-#* +!* .30/3* "#-+%"/#-* '3#* -'%2#&'-* '#&2* '+* 6",50','#* '+.,"2-* '+* -%44+"'* '3#0"* 8#20/,(*2#/0-0+&-?*'3#*0&-'"%/'+"-*/+&2%/'#2*,*;"0#!*@*$%#-1+&?*0&:-#--0+&*4+((7 >&/"(F()+@@&.A(G(>=.3,$%(H$#,"A(I$/"&/"B(7- UB*0-*,*c[:)#,":+(2*8,&*.3+*3,-*;##&*"#!#""#2*'+*,*&#43"+(+60-'*!+"*.+"-#&0&6*"#&,(* !"*=3#/ 0&-%d/0#&/)7**]#*3,-*,*30-'+")*+!*3)4#"'#&-0+&*,&2*')4#*'.+*20,;#'#-*8#((0'%-7**]0-* A3#* 0&-'"%/'+"-* %-#2* '3#* +&(0&#* -%"5#)0&6* '++(* B+((2,22)* C...74+((2,22)7/+8D* "#&,(*!%&/1+&*3,-*2#'#"0+",'#2*+5#"*'3#*4,-'*'.+*)#,"-7**A.+*)#,"-*,6+*30-*/"#,1&0&#* 802:-#--0+&*'+*/,4'%"#*-'%2#&'*"#-4+&-#-*'+*'3#*!+((+.0&6*'.+*$%#-1+&-E .,-*_7K*86e2(7**O0I*8+&'3-*,6+*0'*.,-*_7[*86e2(*,&2*(,-'*.##9*0'*.,-*@7_*86e2(7*]#* has  moderate  hypertension  for  12  years  that  has  been  controlled  with  one  agent.       1. What was the electronic resource of your choice? >05#*)#,"-*,6+*3#*.,-*&+'#2*'+*;#*3)4#"6()/#80/*,&2*,&*+",(*3)4+6()/#80/*,6#&'*.,-* ****@7*F30/3*"#-+%"/#*4"+502#2*'3#*3063#-'*(#5#(*+!*#502#&/#*'+*-%44+"'*)+%"*;+=+8* 0&01,'#27**A3"##*)#,"-*,6+*80/"+,(;%80&%"0,*.,-*&+'#27*A3#*43)-0/0,&*'#((-*UB*'3,'*          line answer? 30-*902&#)*20-#,-#*0-*2%#*'+*,*/+8;0&,1+&*+!*20,;#'#-*,&2*3063*;(++2*4"#--%"#7**]#* #I4(,0&-*'3,'*'30-*90&2*+!*902&#)*20-#,-#*'#&2-*'+*6"+.*4"+6"#--05#()*.+"-#*+5#"*18#?* G#!+"#*2#;"0#H&6*'3#*/,-#-?*-'%2#&'-*.#"#*20"#/'#2*'+*'3#*#8;#22#2*4+((-*+&*'3#* but that there are strategies to reduce the rate of progression. (0;",")* .#;-0'#* ,&2* 605#&* ,* !#.* 80&%'#-* '+* ,&-.#"* '3#* $%#-1+&-7* A3#* 2,',* .,-* E+"/13,*:*Y-0&6*'3#*VNS?*B%;W#2*CN%02#(0&#-*(080'D?*,&2*,*"#-+%"/#*+!*)+%"*/3+0/#?* /+((#/'#2* .0'30&* '3#* B+((2,22)* -0'#* ,&2* '3#&* #I4+"'#2* 0&* #I/#(* !+"8,'* '+* '3#* (+/,(* 2#'#"80&#*0!*UBQ-*;(++2*4"#--%"#*0-*/%""#&'()*.#((*/+&'"+((#2b*<!*&+'?*.3,'*-3+%(2*30-* 3,"22"05#* 088#20,'#()* ,J#"* '3#* -#--0+&7* A3#* 2,',* "#4"#-#&'-* '3#* @KKL* /+3+"'* +!* ',"6#'*;(++2*4"#--%"#*;#b*F3,'*-3+%(2*'3#*&#I'*-'#4-*;#*'+*;#-'*8,&,6#*30-*;(++2* second‐year medical students.  4"#--%"#b*F3,'*;#&#H'-*.+%(2*4+'#&1,(()*+//%"*0!*30-*;(++2*4"#--%"#*.,-*/+&'"+((#2* near the target range? 86/".2&13,/(&,#(7"/+'*/ M**N++6(#*O/3+(,"*.,-*'3#*8+-'*!"#$%#&'()*/0'#2*P"#-+%"/#*+!*/3+0/#Q7 >3,%'+/$3, M* * O'%2#&'-* -##8#2* '+* "#/+6&0R#* STOU* ,&2* VNS* ,-* 4"+5020&6* '3#* 3063#-'* (#5#(* +!* A30-*2,',*/+&H"8-*X*'+*'3#*#I'#&'*'3,'*-%/3*,*-8,((*-,84(#*.0((*,((+.*X*'3,'*,*(,"6#* #502#&/#* !+"* '3#* '.+* 605#&* $%#-1+&-7* * A30-* /+%(2* 4,"'()* ;#* ;#/,%-#* ;+'3* .#"#* &%8;#"**+!*8#20/,(*-'%2#&'-*-#,"/3*N++6(#*,&2*F0904#20,*!+"*/(0&0/,(*0&!+"8,1+&7** 8,&2,'+")* 2,',;,-#-* '+* -#,"/3?* '3+%63* '3,'* 2+#-* &+'* #I4(,0&* .3)* B%;W#2* X* ]+.#5#"?*605#&*'3,'*'3"##**#502#&/#:;,-#2*"#-+%"/#-*:*STOU?*VNS?*,&2*T)&,8#2*X* ,&+'3#"*8,&2,'+")*2,',;,-#*X*.,-*",&9#2*(+.#"*0&*;+'3*/,-#-7** ",&9#2*3063()*0&*'3#*(#5#(*+!*#502#&/#*$%#-1+&?*'3#"#*0-*,(-+*,*-%66#-1+&*'3,'*'3#-#* M**G+'3*4+0&'*+!*/,"#*"#-+%"/#-*T)&,8#2*,&2*Y4A+T,'#*.#"#*3#,50()*%-#2*2#-40'#* -'%2#&'-*/,&*20f#"#&1,'#*;#'.##&*&+&:gGW*,&2*gGW*"#-+%"/#-7** '3#*!,/'*'3,'*-'%2#&'-*3,2*&+'*;##&*-)-'#8,1/,(()*0&'"+2%/#2*'+*#0'3#"*,-*+!*'30-* session.   <&*'#"8-*+!*'#,/30&6?*'3#*%-#*+!*B+((2,22)*802:-#--0+&*4"+502#2*'3#*0&-'"%/'+"-*.0'3* M**G+'3*N++6(#*,&2*F0904#20,*.#"#*,*/+88+&*P"#-+%"/#*+!*/3+0/#Q*!+"*'3#-#*/(0&0/,(* 088#20,'#*0&!+"8,1+&*'+*!##2*;,/9*0&'+*'3#*0&:/(,--*20-/%--0+&-*,;+%'*gGW*,&2*gGW* $%#-1+&-7**W+"#*-%"4"0-0&6*.,-*'3,'*-+8#*-'%2#&'-*'3+%63'*N++6(#*+"*F0904#20,* resources.  4"+502#2*'3#8*.0'3*'3#*3063#-'*(#5#(*+!*#502#&/#7

×